GlassScriptPhysician profile
Xi Zhang
NPI 1457836819
$3,780.58
in general payments reported to CMS, 2019-2025
13 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $500 · 2022: $1,022 · 2023: $910 · 2024: $846 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $1,698.46 | 2021-2023 | Optimizer |
| Abbott Laboratories | $951.45 | 2023-2025 | Aveir, Jot Dx, Tendril |
| Irhythm Technologies, INC. | $491.80 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $169.07 | 2022-2023 | Watchman Access System, Innova Vascular |
| Amgen INC. | $124.98 | 2025 | Repatha |
| Pfizer INC. | $105.86 | 2023-2025 | |
| Biosense Webster, INC. | $84.47 | 2022 | |
| Sanofi-Aventis U.S. LLC | $32.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $27.60 | 2022 | |
| Medtronic, INC. | $27.17 | 2023 | Mycarelink |
| Avinger INC. | $24.31 | 2023 | Pantheris |
| Genzyme Corporation | $22.13 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $20.31 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xi Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.